Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed COO
|
|
Avalon GloboCare Corp. (AVCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS On February 9, 2023 , Avalon GloboCare Corp. entered into and closed an Amended and Restated Membership Interest Purchase Agreement , by and among Avalon Laboratory Services, Inc., a wholly-owned subsidiary of the Company , SCBC Holdings LLC , the Zoe Family Trust, Bryan Cox and Sarah Cox as individuals , and Laboratory Services MSO, LLC. The Amended MIPA amends and restates, in its entirety, that certain Membership Interest Purchase Agreement, dated November 7, 2022 . Pursuant to the terms and conditions set forth in the Amended MIPA, Buyer acquired from the Seller, forty percent of all the issued and outstanding equity interests of Laboratory Services MSO, LLC , free and clear of all liens . The consideration paid by Buyer to Seller f..." |
|
| 04/26/2023 |
8-K/A
| Quarterly results |
| 06/28/2021 |
8-K/A
| Quarterly results |
| 05/31/2018 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 11/29/2017 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ... |
| 11/13/2017 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Audited Financial Statements of Beijing Jieteng (GenExosome) Biotech Co. Ltd. as of December 31, 2016 and 2015, and for the year ended December 31, 2016 and for the period from August 7, 2015 (date of inception) through December 31, 2015",
"Unaudited Financial Statements of Beijing Jieteng (GenExosome) Biotech Co. Ltd. as of June 30, 2017, and for the three and six months ended June 30, 2017 and 2016",
"Pro Forma Financial Information for Avalon GloboCare Corp. and subsidiaries and Beijing Jieteng (GenExosome) Biotech Co. Ltd. as of June 30, 2017, and for the three and six months ended June 30, 2017 and for the year ended December 31, 2016" |
|
|
|